Core Viewpoint - Citigroup has adjusted its profit forecasts for Hengan International (01044) for 2026 and 2027, increasing the target price from HKD 27 to HKD 28.2 while maintaining a "Neutral" rating [1] Group 1: Financial Performance - Hengan's net profit for the second half of 2025 is expected to rebound by 31% year-on-year, driven by a recovery in gross margin from a low base, aligning with Citigroup's expectations [1] - Revenue growth for the second half of 2025 is projected at 4%, meeting forecasts, with improved sales in tissue and hygiene products offsetting declines in other business segments [1] - Gross margins across all business segments in the second half of 2025 are stronger than expected, although lower government subsidies and higher advertising and promotional expenses have offset this, resulting in operating profit and net profit meeting expectations [1] Group 2: Management Outlook - Despite the stable performance in the second half of 2025, management aims to maintain stable sales and profit margins in 2026 due to intense competition and potential pressure from raw material costs [1] - Management plans to address potential challenges by improving product mix and enhancing operational efficiency [1]

Core Viewpoint - UBS has raised its profit forecasts for Hengan International (01044) for 2025 to 2027 by 1% to 4%, and revenue forecasts by 1% to 2%, with the target price increased from HKD 27.7 to HKD 29.5, maintaining a "Buy" rating [1] Financial Performance - For the first half of 2025, Hengan's revenue and net profit decreased by 0.2% and 2.6% respectively, with an expected net profit decline of approximately 12% when excluding foreign exchange gains, which is largely in line with UBS's expectations [1] - Tissue paper business revenue grew by 3% year-on-year, while sanitary napkin revenue fell by 14% [1] Management Insights - Management indicated that the performance of wet wipes is stable, and the competitive landscape in the tissue paper market is better than expected, but sales of sanitary products and mid-to-low-end diapers have declined due to intensified competition [1] Future Outlook - The group anticipates steady growth in tissue paper sales, and an improvement in gross margins for sanitary products in the second half of 2025 [1]